| 89.88 Delayed Data As of 4:02pm ET |  +0.86 / +0.97%Today’s Change | 72.30 Today|||52-Week Range 92.39 | +4.74% Year-to-Date |
| Previous close | 89.02 |
| Today’s open | 89.11 |
| Day’s range | 89.07 - 89.99 |
| Volume | 2,351,243 |
| Average volume (3 months) | 2,662,945 |
| Market cap | $205.7B |
| Earnings growth (last year) | +17.07% |
| Earnings growth (this year) | +9.36% |
| Earnings growth (next 5 years) | +4.95% |
| Revenue growth (last year) | +1.88% |
| P/E ratio | 16.7 |
| Price/Sales | 4.03 |
| Price/Book | 2.78 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.87 | +1.10% |
| PFEPfizer | +0.43 | +1.02% |
| ABBVAbbVie | +0.33 | +0.41% |
| ABTAbbott Laboratories | +1.28 | +1.73% |
| Next reporting date | April 24, 2019 |
| EPS forecast (this quarter) | $1.27 |
| Annual revenue (last year) | $49.4B |
| Annual profit (last year) | $7.7B |
| Net profit margin | 15.69% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer Vasant Narasimhan |
Chief Financial Officer Harry Werner Kirsch |
Corporate headquarters Basel, Basel-stadt (basle Town) |
